The association between placebo arm inclusion and adverse event rates in antidepressant randomized controlled trials: An examination of the Nocebo Effect
Christian P. Cheung(University of Guelph), Mark Sinyor(Sunnybrook Health Science Centre), Ari Juda(University of Toronto), Krista L. Lanctôt(Sunnybrook Health Science Centre), Anthony Levitt(University of Toronto), Ayal Schaffer(University of Toronto), Mathura T. Thiyagarajah(Sunnybrook Health Science Centre), Celina S. Liu(Sunnybrook Health Science Centre), Haben Y. Abraha(Sunnybrook Health Science Centre), Mahwesh Saleem(Sunnybrook Health Science Centre), Amy Cheung(Sunnybrook Health Science Centre), Alex Kiss(Sunnybrook Health Science Centre)
Cited by 6
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Suicide risk and prevention during the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.6k
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
|Bipolar Disorders|2012|1.2k
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
|The Canadian Journal of Psychiatry|2016|1.1k